Columbia Seligman Premium Technology Growth Fund offers strong returns and dividends & trades at 4.47% discount to NAV. Learn ...
STK offers diverse tech exposure with a 6.7% dividend yield, utilizing a dynamic covered call option strategy to generate income despite tech sector volatility. Despite a 12% price decline in 2025, ...
MENLO PARK, Calif.--(BUSINESS WIRE)--Synthekine Inc., an engineered cytokine therapeutics company, today announced it is advancing its IL-2 partial agonist, STK-012, into clinical investigation ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback